EP3484477 - Bibliographic data
TRAITEMENT DU CANCER
| Last update | 12/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Mingsight Pharmaceuticals, Inc. P.O. Box 261208
San Diego, CA 92196
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Michael NIESMAN P.O. Box 261208
San Diego
California 92196
États-Unis d'Amérique
Kai ZHANG P.O. Box 261208
San Diego
California 92196
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Mewburn Ellis LLP Aurora Building
Counterslip
Bristol BS1 6BX
Royaume-Uni
|
| (21) Request number | EP17828498.0 |
|---|---|
| (22) Request date | 13/07/2017 |
| (11) Publication number | EP3484477 |
|---|---|
| Publication date | 13/09/2023 |
| (54) Title of the invention | TRAITEMENT DU CANCER |
|---|---|
| (51) International classification | A61K 31/52, C07D 487/04, A61K 31/519, A61K 31/506, A61P 35/02, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201662362369 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 8 -
Amount: 160 € -
Due date 31/07/2024
Surtax: 8 - Amount: 32 € - Due date 03/02/2025 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 13/09/2023 Entrée en période de grâce du brevet d'invention - Legal date 01/08/2024 Déchéance du brevet d'invention après période de grâce - Legal date 31/07/2024 |